"Am I carrier?" The patient's lived experience of thrombophilia genetic screening and its outcome

Health Psychology and Behavioral Medicine
Guendalina GraffignaElena Vegni

Abstract

How do patients with thrombophilia experience a physician's request to undergo a genetic test? How do they experience the test outcome? To answer these questions, we conducted an interpretative phenomenological analysis study, based on 10 in-depth interviews with patients who underwent genetic testing for thrombophilia in Italy, half with positive and half with negative results. The experience of undergoing genetic screening for thrombophilia plays an important role in reconfiguring patients' signification of their illness experience. A positive outcome becomes a cue to reorganize in a more adaptive way the illness meaning at the cognitive and emotive levels, whereas a negative outcome appears more distressing and confusing. As a clinical implication of the study, clinicians should consider communicating carefully with the patients regardless from the positive/negative test results and they should explore the patient's specific reaction and understanding of test result.

References

Apr 2, 1998·BMJ : British Medical Journal·T M Marteau, R T Croyle
Nov 26, 1999·Social Science & Medicine·C ShawT M Marteau
Oct 20, 2000·European Journal of Human Genetics : EJHG·M BroadstockT Marteau
Feb 16, 2002·Journal of Behavioral Medicine·Susan MichieTheresa M Marteau
Jul 23, 2003·Journal of Thrombosis and Haemostasis : JTH·I Martinelli
Jul 23, 2003·Journal of Thrombosis and Haemostasis : JTH·S J Machin
Sep 17, 2003·Clinical Genetics·E W AlmqvistUNKNOWN Canadian Collaborative Study of Predictive Testing
Nov 25, 2003·Journal of Thrombosis and Haemostasis : JTH·E A HellmannS Moll
Feb 5, 2005·Pathophysiology of Haemostasis and Thrombosis·Trevor Baglin
Feb 12, 2005·Seminars in Thrombosis and Hemostasis·Mark S Hertzberg
Apr 2, 2005·Qualitative Health Research·Donna GoodmanDavid Bossingham
Jun 7, 2006·Social Science & Medicine·Paula M SaukkoJohn L Campbell
Feb 22, 2008·Journal of Genetic Counseling·J HeshkaP S Wells
Apr 9, 2008·La Revue de médecine interne·J ConstansC Conri
Apr 16, 2009·Qualitative Health Research·Guendalina Graffigna, Kärin Olson
Jul 9, 2009·Medical Care·Kelly B Haskard Zolnierek, M Robin Dimatteo
Jul 6, 2010·European Journal of Cancer Care·A F MendesL Sousa
Sep 21, 2010·Qualitative Health Research·Audrey TluczekLaura Cavanagh
Mar 1, 2002·Journal of Health Psychology·Elizabeth Chapman, Jonathan A Smith
Mar 1, 2002·Journal of Health Psychology·Victoria SeniorTheresa M Marteau
Dec 20, 2011·Patient Education and Counseling·Elena VegniEgidio A Moja
Apr 21, 2012·Journal of Health Psychology·Jennifer HilgartKathryn Thirlaway

❮ Previous
Next ❯

Software Mentioned

IPA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.